Workflow
Psilocybin research and development
icon
Search documents
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company's Netherlands Facility via USA Controlled Substances Permit
Newsfile· 2025-07-14 11:45
Core Viewpoint - Red Light Holland has successfully shipped its naturally occurring psilocybin from its Netherlands facility to Irvine Labs in California, marking a significant milestone in their partnership and advancing their goal of developing microdosing capsules for global distribution [2][4][5]. Group 1: Shipment and Partnership - The shipment of psilocybin was made possible through the approval of a United States Controlled Substances import permit and the securing of a DEA quota [2][3]. - This first global shipment represents a groundbreaking milestone in the collaboration between Red Light Holland and Irvine Labs, with potency testing and shelf life extension protocols currently underway [3][5]. Group 2: Product Development and Research - The partnership aims to develop a commercialized and standardized psilocybin product that can be legally sold in emerging markets and utilized in government-funded pilot programs and clinical trials in the United States [5]. - Red Light Holland is focused on overcoming challenges in product development and manufacturing by implementing proprietary preservation technology to maintain the integrity of natural compounds while extending product shelf life [6]. Group 3: Future Plans and Capacity - Irvine Labs has the capacity for larger shipments under its existing 2025 DEA quota, allowing for the scaling of research and development efforts following the initial shipment [7]. - The companies plan to conduct comprehensive potency testing and shelf life extension testing of the delivered psilocybin materials, with future larger shipments already being planned [11].
Red Light Holland's Partner FDA-Compliant and DEA-Registered Irvine Labs Receives 2025 Psilocybin DEA Quotas, Including Import Quota
Newsfile· 2025-04-15 12:50
Core Viewpoint - Red Light Holland Corp. has achieved a significant milestone by securing the 2025 psilocybin DEA quotas through its research and development partner, Irvine Labs, enabling the import of natural psilocybin products from the Netherlands to the United States [1][4][7]. Group 1: Company Overview - Red Light Holland is an Ontario-based corporation focused on the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as psilocybin truffles in the Netherlands [1][8]. - Irvine Labs, established in 1997, specializes in medical research and development, particularly in natural medicines, and is licensed for prescription and over-the-counter drug manufacturing [3][6]. Group 2: Partnership and Milestones - The partnership between Red Light Holland and Irvine Labs aims to develop a commercialized product for legal export to emerging markets and participation in government-funded pilot programs and clinical trials in the U.S. [5]. - The successful receipt of the 2025 psilocybin import quota by Irvine Labs is a critical milestone, allowing the companies to proceed with the import permit application process [4][7]. Group 3: Product Development and Innovation - Red Light Holland and Irvine Labs are focused on developing proprietary dehydration and packaging solutions to extend the shelf life of psilocybin microdosing capsules [4]. - The collaboration aims to address challenges in preserving psilocybin from natural compounds through advanced manufacturing and storage protocols [4].